IDEXX LABS INC. DL-,10IDEXX LABS INC. DL-,10IDEXX LABS INC. DL-,10

IDEXX LABS INC. DL-,10

No trades
See on Supercharts
Market capitalization
‪38.33 B‬EUR
‪765.62 M‬EUR
‪3.32 B‬EUR
‪82.27 M‬
Beta (1Y)
1.76

About IDEXX LABS INC. DL-,10

CEO
Jonathan J. Mazelsky
Website
Headquarters
Westbrook
Employees (FY)
‪11 K‬
Founded
1983
FIGI
BBG000GBSPD7
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of IX1 is 458.6 EUR — it has decreased by 0.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange IDEXX LABS INC. DL-,10 stocks are traded under the ticker IX1.
IDEXX LABS INC. DL-,10 is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
IX1 stock is 0.35% volatile and has beta coefficient of 1.76. Check out the list of the most volatile stocks — is IDEXX LABS INC. DL-,10 there?
IX1 earnings for the last quarter are 2.39 EUR per share, whereas the estimation was 2.24 EUR resulting in a 6.72% surprise. The estimated earnings for the next quarter are 1.92 EUR per share. See more details about IDEXX LABS INC. DL-,10 earnings.
IDEXX LABS INC. DL-,10 revenue for the last quarter amounts to ‪866.08 M‬ EUR despite the estimated figure of ‪876.82 M‬ EUR. In the next quarter revenue is expected to reach ‪808.05 M‬ EUR.
Yes, you can track IDEXX LABS INC. DL-,10 financials in yearly and quarterly reports right on TradingView.
IX1 stock has risen by 2.62% compared to the previous week, the month change is a 6.02% fall, over the last year IDEXX LABS INC. DL-,10 has showed a 4.54% increase.
IX1 net income for the last quarter is ‪176.24 M‬ EUR, while the quarter before that showed ‪200.77 M‬ EUR of net income which accounts for −12.22% change. Track more IDEXX LABS INC. DL-,10 financial stats to get the full picture.
Today IDEXX LABS INC. DL-,10 has the market capitalization of ‪38.39 B‬, it has decreased by 2.35% over the last week.
No, IX1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IX1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IDEXX LABS INC. DL-,10 stock right from TradingView charts — choose your broker and connect to your account.
IX1 reached its all-time high on Aug 5, 2021 with the price of 595.6 EUR, and its all-time low was 10.8 EUR and was reached on Dec 5, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has ‪11.00 K‬ employees. See our rating of the largest employees — is IDEXX LABS INC. DL-,10 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IDEXX LABS INC. DL-,10 technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IDEXX LABS INC. DL-,10 stock shows the buy signal. See more of IDEXX LABS INC. DL-,10 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on IDEXX LABS INC. DL-,10 future price: according to them, IX1 price has a max estimate of 633.65 EUR and a min estimate of 535.08 EUR. Read a more detailed IDEXX LABS INC. DL-,10 forecast: see what analysts think of IDEXX LABS INC. DL-,10 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IDEXX LABS INC. DL-,10 EBITDA is ‪1.10 B‬ EUR, and current EBITDA margin is 32.98%. See more stats in IDEXX LABS INC. DL-,10 financial statements.